✦ LIBER ✦

Efficacy and Tolerability of the DPP-4 Inhibitor Alogliptin Combined with Pioglitazone, in Metformin-Treated Patients with Type 2 Diabetes

✍ Scribed by DeFronzo, R. A.; Burant, C. F.; Fleck, P.; Wilson, C.; Mekki, Q.; Pratley, R. E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Tolerability of Pioglitazon

✍ Professor Giuseppe Derosa 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 198 KB

Linagliptin (BI 1356), a potent and sele

✍ T. Forst; B. Uhlig-Laske; A. Ring; U. Graefe-Mody; C. Friedrich; K. Herbach; H.- 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB

Glycemic Improvement with Fixed-Dose Com

✍ Bajaj, Harpreet; Venn, Karri; Stein, Eden; Ye, Chenglin; Aronson, Ronnie 📂 Article 📅 2014 🏛 Canadian Diabetes Association 🌐 English ⚖ 160 KB

Efficacy and tolerability of initial com

✍ J. Rosenstock; S. W Kim; M. A. Baron; R.-P. Camisasca; F. Cressier; A. Couturier 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB

Safety and efficacy of teneligliptin: a

✍ Otsuki, Hideo; Kosaka, Takeo; Nakamura, Kenzo; Shimomura, Fumihiko; Kuwahara, Yo 📂 Article 📅 2013 🏛 Springer Netherlands 🌐 English ⚖ 251 KB

Efficacy and safety of the dipeptidyl pe

✍ Pratley, Richard E.; Reusch, Jane E.-B.; Fleck, Penny R.; Wilson, Craig A.; Mekk 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 282 KB